SYBX
Synlogic Inc
NASDAQ: SYBX · HEALTHCARE · BIOTECHNOLOGY
$0.63
-2.93% today
Updated 2026-04-30
Market cap
$7.49M
P/E ratio
—
P/S ratio
936.86x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Synlogic Inc (SYBX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.52M | $-6.50M | $-13.97M | $-21.14M | $-24.80M | $-31.05M | $-42.47M | $-75.47M | $-39.55M | $-52.20M | $-56.89M | $-51.61M | $-31.66M | $-4.36M |
| Capital expenditures | $0.00 | $7000.00 | $102000.00 | $251000.00 | $1.73M | $2.58M | $5.65M | $1.25M | $395000.00 | $679000.00 | $728000.00 | $214000.00 | $14000.00 | $0.00 |
| Depreciation | $37000.00 | $36000.00 | $35000.00 | $54000.00 | $159000.00 | $2.31M | $2.42M | $2.70M | $2.64M | $2.44M | $2.52M | $1.96M | $347000.00 | — |
| Stock-based comp | $24000.00 | $163000.00 | $408000.00 | $985000.00 | $1.59M | $2.65M | $4.32M | $4.13M | $3.91M | $3.36M | $3.64M | $2.81M | $3.17M | $117000.00 |
| Free cash flow | $-4.52M | $-6.50M | $-14.07M | $-21.39M | $-26.53M | $-33.63M | $-48.12M | $-76.72M | $-39.95M | $-52.88M | $-57.62M | $-51.83M | $-31.67M | $-4.36M |
| Investing cash flow | — | $-7000.00 | $-102000.00 | $-251000.00 | $-48.49M | $9.28M | $-87.20M | $10.80M | $32.48M | $-53.25M | $58.35M | $38.77M | $25.34M | — |
| Financing cash flow | $16.85M | $16.42M | $209000.00 | $101.78M | $16000.00 | $66.68M | $82.48M | $79.60M | $13.39M | $89.38M | $-2.04M | $20.94M | $172000.00 | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $80.39M | $-73.28M | $44.90M | $-47.19M | $14.93M | $6.32M | $-16.07M | — | — | — | — |